Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo.
about
Activation of phenylalanine hydroxylase induces positive cooperativity toward the natural cofactorA new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeuticsPharmacological chaperoning: a primer on mechanism and pharmacologyProtein homeostasis disorders of key enzymes of amino acids metabolism: mutation-induced protein kinetic destabilization and new therapeutic strategies.Influence of PAH Genotype on Sapropterin Response in PKU: Results of a Single-Center Cohort Study.Novel pharmacological chaperones that correct phenylketonuria in mice.Up to date knowledge on different treatment strategies for phenylketonuria.Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype.Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.Recombinant heteromeric phenylalanine monooxygenase and the oxygenation of carbon and sulfur substrates.Mapping the functional landscape of frequent phenylalanine hydroxylase (PAH) genotypes promotes personalised medicine in phenylketonuria.Long-term pharmacological management of phenylketonuria, including patients below the age of 4 years.Sapropterin treatment does not enhance the health-related quality of life of patients with phenylketonuria and their parents.Pharmacological Chaperones: Beyond Conformational Disorders.Prevalence of tetrahydrobiopterine (BH4)-responsive alleles among Austrian patients with PAH deficiency: comprehensive results from molecular analysis in 147 patients.
P2860
Q24293412-F39F7210-5B01-4D7F-B2BE-AE97051DDFBAQ24617497-9A0D12A2-0096-430D-9EAF-28086BA687FEQ27001695-B205F923-CE5D-48E5-BEE6-FFF3798B49BCQ30355120-272F3125-33FF-4B7A-AAF3-8F9F3BD8DE07Q33947342-C1D2E2D7-781B-4FB4-85EB-688CC46D02E3Q34127906-DA2D5E76-AE6F-45C7-BB01-D9F240F4FFF3Q35623929-F75979D6-FCBF-41C7-9025-124D8E4C0E26Q37014366-DB7860F7-9F94-4F9E-8038-A8E71A4AF83BQ38200933-B16F7402-66AB-4DCC-ADE8-0D66C34FA218Q39576528-CF7CA934-138A-441C-B38F-F6F65D6F436DQ41571007-434C7F16-0216-4566-BEFF-A7B31B357410Q42367760-0D3E3449-BD5B-4956-A0E4-1F4776A4870DQ47430897-6C9477DF-DB16-4A38-9E9A-D847BDFBDAAAQ47602237-42714757-26E7-4E57-B243-86AAE9B3CD1DQ47865401-F370416F-89B1-4C0A-8BF9-1BF1528FF22D
P2860
Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Pahenu1 is a mouse model for t ...... l chaperone mechanism in vivo.
@en
Pahenu1 is a mouse model for t ...... l chaperone mechanism in vivo.
@nl
type
label
Pahenu1 is a mouse model for t ...... l chaperone mechanism in vivo.
@en
Pahenu1 is a mouse model for t ...... l chaperone mechanism in vivo.
@nl
prefLabel
Pahenu1 is a mouse model for t ...... l chaperone mechanism in vivo.
@en
Pahenu1 is a mouse model for t ...... l chaperone mechanism in vivo.
@nl
P2093
P921
P356
P1476
Pahenu1 is a mouse model for t ...... l chaperone mechanism in vivo.
@en
P2093
Adelbert A Roscher
Ania C Muntau
Anna Eichinger
Clemens Zsifkovits
Dunja D Messing
Florian B Lagler
Hartmut Glossmann
Katharina A Domdey
Kristina F Kemter
Marta K Danecka
P304
P356
10.1093/HMG/DDQ085
P577
2010-02-23T00:00:00Z